Tetra Bio-Pharma Inc.
TBPMQ
$0.00
$0.000.00%
OTC PK
| 08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | 08/31/2021 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 369.50K | 1.37M | 2.90M | 3.82M | 6.78M |
| Total Receivables | 1.21M | 1.59M | 2.02M | 199.80K | 228.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 138.40K | 192.10K | 829.30K | 631.20K | 1.38M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.72M | 3.15M | 5.75M | 4.65M | 8.39M |
|
|
|||||
| Total Current Assets | 1.72M | 3.15M | 5.75M | 4.65M | 8.39M |
| Net Property, Plant & Equipment | 479.10K | 512.20K | 529.00K | 540.80K | 556.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | 18.96M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 111.80K | 231.10K | 230.80K | 171.40K | 462.80K |
| Total Assets | 2.31M | 3.89M | 6.94M | 5.90M | 29.26M |
|
|
|||||
| Total Accounts Payable | 5.56M | 4.24M | 4.22M | 3.27M | 2.67M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 1.27M | 1.70M | 2.09M | 2.43M | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 215.80K | -- | -- |
| Total Other Current Liabilities | -- | -- | 215.80K | -- | -- |
| Total Current Liabilities | 6.83M | 5.94M | 6.53M | 5.70M | 2.67M |
|
|
|||||
| Total Current Liabilities | 6.83M | 5.94M | 6.53M | 5.70M | 2.67M |
| Long-Term Debt | -- | -- | -- | -- | 2.37M |
| Short-term Debt | 1.27M | 1.70M | 2.09M | 2.43M | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.83M | 5.94M | 6.53M | 5.70M | 5.04M |
|
|
|||||
| Common Stock & APIC | 85.42M | 85.89M | 85.21M | 83.50M | 82.63M |
| Retained Earnings | -103.68M | -104.34M | -101.31M | -99.00M | -76.37M |
| Treasury Stock & Other | 13.74M | 16.41M | 16.51M | 15.69M | 17.96M |
| Total Common Equity | -4.52M | -2.04M | 415.90K | 194.80K | 24.22M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -4.52M | -2.04M | 415.90K | 194.80K | 24.22M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.52M | -2.04M | 415.90K | 194.80K | 24.22M |
|
|
|||||